XLON
MET
Market cap1mUSD
Mar 11, Last price
0.78GBP
Name
Microsaic Systems PLC
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Microsaic Systems plc, established in 1998 with its headquarters in Woking, UK, focuses on the creation, advancement, and worldwide marketing of compact mass spectrometry (MS) instruments. The company operates globally, with a presence across the United Kingdom, Japan, the United States, Europe, China, South Korea, and other international markets. It provides portable analytical solutions designed for real-time monitoring across diverse sectors, including water management, pharmaceuticals, chemical manufacturing, academic research, and the food and beverage industry. Its product range includes the MiD platform for MS detection, such as the 4500 MiD; the MiDas Automated Sampling interface, which streamlines direct MS analysis through automated sample handling; and the MiD Protein ID, another miniaturized mass spectrometer. Additionally, Microsaic Systems supplies vital consumables and spare parts for its systems. These innovations are crucial for applications in the pharmaceutical and biopharmaceutical fields, food safety, environmental analysis, and clinical diagnostics. The company further extends its services through comprehensive support and training programs, distributing its products via original equipment manufacturers (OEMs) and a network of distributors.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||